Cargando…
Non-viral approaches for gene therapy and therapeutic genome editing across the blood–brain barrier
The success of brain-targeted gene therapy and therapeutic genome editing hinges on the efficient delivery of biologics bypassing the blood–brain barrier (BBB), which presents a significant challenge in the development of treatments for central nervous system disorders. This is particularly the case...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357415/ https://www.ncbi.nlm.nih.gov/pubmed/37485250 http://dx.doi.org/10.1007/s44258-023-00004-0 |